169 related articles for article (PubMed ID: 35272421)
1. [Expert consensus on clinical diagnosis and treatment of portal hypertension with hepatocellular carcinoma (2022)].
Chinese Society of Spleen and Portal Hypertension Surgery, Chinese Society of Surgery, Chinese Medical Association
Zhonghua Wai Ke Za Zhi; 2022 Apr; 60(4):310-320. PubMed ID: 35272421
[TBL] [Abstract][Full Text] [Related]
2. Chinese expert consensus on multidisciplinary diagnosis and treatment of hepatocellular carcinoma with portal vein tumor thrombus: 2016 edition.
Cheng S; Chen M; Cai J;
Oncotarget; 2017 Jan; 8(5):8867-8876. PubMed ID: 27780939
[TBL] [Abstract][Full Text] [Related]
3. Portal hypertension associated with hepatocellular carcinoma with cirrhosis.
Cooney TG; Bauer DC; Knauer CM
Am J Gastroenterol; 1980 Nov; 74(5):436-8. PubMed ID: 6263084
[TBL] [Abstract][Full Text] [Related]
4. Liver surgery in cirrhosis and portal hypertension.
Hackl C; Schlitt HJ; Renner P; Lang SA
World J Gastroenterol; 2016 Mar; 22(9):2725-35. PubMed ID: 26973411
[TBL] [Abstract][Full Text] [Related]
5. Investigating the risk factors of hepatocellular carcinoma and survival analysis for cirrhosis after transjugular intrahepatic portosystemic shunt in treating portal hypertension.
Wei J; Li H; Li C
J Cancer Res Ther; 2018; 14(4):826-832. PubMed ID: 29970660
[TBL] [Abstract][Full Text] [Related]
6. A pragmatic strategy for the screening and treatment of portal hypertension in patients needing systemic treatment for advanced hepatocellular carcinoma.
Piscaglia F; La Mura V; Ravaioli F
Dig Liver Dis; 2023 Aug; 55(8):997-1000. PubMed ID: 37321913
[No Abstract] [Full Text] [Related]
7. Development of a nomogram to predict outcome after liver resection for hepatocellular carcinoma in Child-Pugh B cirrhosis.
Berardi G; Morise Z; Sposito C; Igarashi K; Panetta V; Simonelli I; Kim S; Goh BKP; Kubo S; Tanaka S; Takeda Y; Ettorre GM; Wilson GC; Cimino M; Chan CY; Torzilli G; Cheung TT; Kaneko H; Mazzaferro V; Geller DA; Han HS; Kanazawa A; Wakabayashi G; Troisi RI
J Hepatol; 2020 Jan; 72(1):75-84. PubMed ID: 31499131
[TBL] [Abstract][Full Text] [Related]
8. Management of small hepatocellular carcinoma in cirrhosis: focus on portal hypertension.
Hernandez-Gea V; Turon F; Berzigotti A; Villanueva A
World J Gastroenterol; 2013 Feb; 19(8):1193-9. PubMed ID: 23482437
[TBL] [Abstract][Full Text] [Related]
9. [Expert consensus on precise diagnosis and management of primary hepatocellular carcinoma in advanced stage (2023 version)].
; ;
Zhonghua Gan Zang Bing Za Zhi; 2023 Sep; 31(9):910-920. PubMed ID: 37872086
[TBL] [Abstract][Full Text] [Related]
10. [Synopsis: Diagnosis and treatment of hepatocellular carcinoma in patients with cirrhosis].
Ganne-Carrié N; Mohand D; N'kontchou G; Grando-Lemaire V; Trinchet JC
Gastroenterol Clin Biol; 2002 Jan; 26(1):73-7. PubMed ID: 11938045
[No Abstract] [Full Text] [Related]
11. Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients.
Giannini EG; Savarino V; Farinati F; Ciccarese F; Rapaccini G; Marco MD; Benvegnù L; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F;
Liver Int; 2013 Nov; 33(10):1594-600. PubMed ID: 23654354
[TBL] [Abstract][Full Text] [Related]
12. Risk Factors for Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt in Patients with Hepatocellular Carcinoma and Portal Hypertension.
Yao J; Zuo L; An G; Yue Z; Zhao H; Wang L; Liu F
J Gastrointestin Liver Dis; 2015 Sep; 24(3):301-7. PubMed ID: 26405702
[TBL] [Abstract][Full Text] [Related]
13. A preliminary study on surgery for hepatocellular carcinoma patients with portal hypertension.
Duan YF; Li XD; Sun DL; Chen XM; An Y; Zhu F
Am J Surg; 2015 Jul; 210(1):129-33. PubMed ID: 25457251
[TBL] [Abstract][Full Text] [Related]
14. [Multidisciplinary experts consensus on diagnosis and treatment of precancerous lesions of hepatocellular carcinoma (2023 version)].
;
Zhonghua Gan Zang Bing Za Zhi; 2023 Dec; 31(12):1250-1261. PubMed ID: 38253068
[TBL] [Abstract][Full Text] [Related]
15. Is portal hypertension a contraindication to hepatic resection?
Cucchetti A; Ercolani G; Vivarelli M; Cescon M; Ravaioli M; Ramacciato G; Grazi GL; Pinna AD
Ann Surg; 2009 Dec; 250(6):922-8. PubMed ID: 19855258
[TBL] [Abstract][Full Text] [Related]
16. Relationship between indocyanine green retention test, decompensation and survival in patients with Child-Pugh A cirrhosis and portal hypertension.
Lisotti A; Azzaroli F; Cucchetti A; Buonfiglioli F; Cecinato P; Calvanese C; Simoni P; Arena R; Montagnani M; Golfieri R; Colecchia A; Festi D; Mazzella G
Liver Int; 2016 Sep; 36(9):1313-21. PubMed ID: 26786880
[TBL] [Abstract][Full Text] [Related]
17. [Portal hypertension and hepatocellular carcinoma in patients with alcoholic cirrhosis].
Bataille C; Bercoff E; Lebrec D
Acta Gastroenterol Belg; 1983; 46(1-2):18-20. PubMed ID: 6316702
[No Abstract] [Full Text] [Related]
18. Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: A systematic review and meta-analysis. More doubts than clarity.
Cucchetti A; Cescon M; Pinna AD
Hepatology; 2015 Sep; 62(3):976-7. PubMed ID: 25598405
[No Abstract] [Full Text] [Related]
19. [Portal hypertension in localized hepatocellular carcinoma without cirrhosis].
Streifler I; Dux S; Pitlik S
Harefuah; 1982 Jan; 102(2):64-5. PubMed ID: 6284600
[No Abstract] [Full Text] [Related]
20. Portal hypertension and development of hepatocellular carcinoma: factors influencing significance in prognostic models.
Christensen E
J Hepatol; 2009 May; 50(5):848-9. PubMed ID: 19299028
[No Abstract] [Full Text] [Related]
[Next] [New Search]
